Korea University Guro Hospital

Guro-gu, Seoul 152703

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Cancer, HER-2 Protein Overexpression, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Salivary Gland Cancer, Urothelial Carcinoma

Studies at this site

• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — Recruiting now
• A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label — Stopped early